Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,545.5
-13.6 (-0.53%)

 

  • STI Straits Times Index
    2,545.5
    -13.6 (-0.53%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,578.1
    -10.4 (-0.66%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,531.6
    -399.0 (-1.60%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,354.0
    -32.4 (-0.96%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,329.9
    -88.2 (-0.39%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,143.9
    -34.4 (-0.66%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,268.2M
  • Value: 1,358.8M
  • Rise: 113
  • Fall: 217
  • Unch: 478

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008+0.001
ThaiBev0.605-0.020
Genting Sing0.680-0.030
Asian Healthcare0.285+0.050
Vicplas Intl0.390+0.065
ISDN0.395+0.030
AsiaMedic0.023+0.002
CNMC Goldmine0.360+0.015
Rex Intl0.184-0.003
Medtecs Intl0.970-0.030

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,253.8 -296.2
HSCEI 9,745.8 -107.4
Jakarta 4,863.1 -41.0
Nikkei 225 22,064.8 -447.3
SSE Comp 2,959.0 -11.7
Shanghai A 3,101.5 -12.2
Shanghai B 211.6 -1.8
KOSPI 2,100.4 -34.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

UG Healthcare UG HEALTHCARE CORPORATION LTD
Quotes 10 Minutes Delayed. Updated at 07 Aug 2020 17:14
Last (SGD): 3.260 Change: -0.040 High: 3.440 Remarks: -
Change (%): -1.21 Low: 3.160
Open 3.380 Yesterday's Close 3.300
Buy Price 3.250 Sell Price 3.260
Buy Volume ('000) 22.8 Sell Volume ('000) 3.0
Cumulative Volume ('000) 8,240.8 Cumulative Value 27,284,725
Click to show Stock Prices chart

Latest News

View All News

Key Statistics

EPS (SGD) a 0.01278 Trailing EPS (SGD) e 0.01037 NAV (SGD) b 0.2166
PE a 255.086 Trailing PE f 314.289 Price / NAV b 15.0508
Dividend (SGD) d 0.002553 Cash In Hand (SGD) g 0.0167 Issued & Paid-up Shares c 196,093,000
Dividend Yield (%) d 0.078 Price / Cash In Hand g 195.210 Treasury Shares h -
Beta - 75 Daysi 0.387 R-Squared - 75 Days(%)i 0.40 Market Cap (M) 639.263
Beta - 500 Daysi 0.113 R-Squared - 500 Days (%)i 0.08 Enterprise Value (M) 676.161
Piotroski F Score 3 Exchange Code 41A Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 114.1712 6-Month VWAP 0.867 Free Float (%) -
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 17 Feb 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference UG Healthcare SGX 639.263 255.086 314.289 15.0508 0.078
Industry Medical & Biotechnology SGX 944.027 20.913 19.127 1.3019 2.032
Medical Specialties SGX 4,408.757 225.591 126.517 20.5664 0.240
Local Peer Top Glove SGX 25,114.437 206.078 117.261 22.8874 0.251
Local Peer Medtecs Intl SGX 532.929 340.351 340.529 6.2219 -
Local Peer Biolidics SGX 105.445 - - 9.6890 -
Local Peer Yunnan Energy SGX 43.794 - - 0.9014 -
Local Peer Annica SGX 16.675 - - 3.3333 -
Global Peer ABBOTT LABORATORIES NYSE 179,230.752 48.890 58.324 5.8614 1.298
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 163,904.390 44.346 44.227 5.4863 0.185
Global Peer DANAHER CORP NYSE 145,712.609 58.547 49.883 4.4163 0.325
Global Peer MEDTRONIC PLC NYSE 134,197.065 28.022 28.022 2.6450 2.159
Global Peer INTUITIVE SURGICAL INC NASDAQ 80,262.282 58.191 70.653 9.1828 -
Global Peer BECTON DICKINSON & CO NYSE 74,325.310 68.693 96.028 3.0943 1.128
Global Peer STRYKER CORP NYSE 71,943.573 34.538 44.937 5.6409 1.111
Global Peer BOSTON SCIENTIFIC CORP NYSE 55,753.210 11.862 14.008 3.5703 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 47,921.388 36.689 43.010 3.8958 1.704
Global Peer EDWARDS LIFESCIENCES CORP NYSE 47,836.753 45.694 64.331 12.4603 -
Other Global Peers DEXCOM INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), IDEXX LABORATORIES INC (NASDAQ), ALCON AG (NYSE), AGILENT TECHNOLOGIES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), TOPGLOV (Bursa), HOLOGIC INC (NASDAQ), TELEFLEX INC (NYSE), COOPER COS INC (NYSE), HARTA (Bursa), VARIAN MEDICAL SYSTEMS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), PERKINELMER INC (NYSE), WATERS CORP (NYSE), STERIS PLC (NYSE), WEIGAO GROUP (HKEx), MASIMO CORPORATION (NASDAQ), QUIDEL CORP (NASDAQ), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), MICROPORT (HKEx), COCHLEAR LTD (ASX), PENUMBRA INC (NYSE), NOVOCURE LTD (NASDAQ), SUPERMX (Bursa), BRUKER CORPORATION (NASDAQ), TANDEM DIABETES CARE INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), GLOBUS MED INC (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), NEVRO CORP (NYSE), KANGJI MEDICAL (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), WRIGHT MEDICAL GROUP NV (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), ICU MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), INARI MEDICAL INC (NASDAQ), AK MEDICAL (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), NUVASIVE INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), STAAR SURGICAL CO (NASDAQ), CONMED CORP (NYSE), PEIJIA-B (HKEx), EBOS GROUP (ASX), LIVANOVA PLC (NASDAQ), CANTEL MEDICAL CORP (NYSE), GLAUKOS CORPORATION (NYSE), ATRICURE INC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), AVANOS MEDICAL INC (NYSE), BIOTELEMETRY INC (NASDAQ), NANOSONICS LIMITED (ASX), MESA LABORATORIES INC (NASDAQ), CIRC (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), KDL MEDICAL (HKEx), ATRION CORP (NASDAQ), CERUS CORP (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), INMODE LTD (NASDAQ), LIFETECH SCI (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CRYOLIFE INC (NYSE), VAPOTHERM INC (NYSE), INOGEN INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), VERICEL CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), NATUS MEDICAL INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ZYNEX INC (NASDAQ), SI BONE INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), AXOGEN INC (NASDAQ), VIEWRAY INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), YESTAR HEALTH (HKEx), REPRO MEDSYSTEMS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), PW MEDTECH (HKEx), RETRACTABLE TECHNOLOGIES INC (NYSE American), AROA BIOSURGERY LTD (ASX), GOLDEN MEDITECH (HKEx), PROFOUND MED CORP (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), PULSE BIOSCIENCES INC (NASDAQ), ALPHA PRO TECH (NYSE American), IRADIMED CORP (NASDAQ), CUTERA INC (NASDAQ), MISONIX INC (NASDAQ), INVACARE CORP (NYSE), CORMEDIX INC (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), ACCURAY INCORPORATED (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), DERMTECH INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SIENTRA INC (NASDAQ), VINCENT MED (HKEx), TELA BIO INC (NASDAQ), FONAR CORP (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), MODERN DENTAL (HKEx), LKL (Bursa), ELECTROMED INC (NYSE American), SOLITON INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), NEMAURA MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), INTRICOM CORP (NASDAQ), BIOMERICA INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), PAVMED INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), ELECTROCORE INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), RESAPP HEALTH LIMITED (ASX), CYCLOPHARM LIMITED (ASX), SOMNOMED LIMITED (ASX), DAXOR CORP (NYSE American), NEPHROS INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), YUNNAN ENERGY (HKEx), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), RESPIRI LTD (ASX), DIMERIX LTD (ASX), NEURONETICS INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), SDI LTD (ASX), IMPEDIMED LIMITED (ASX), COMPUMEDICS (ASX), ONCOCYTE CORP (NYSE American), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), CONFORMIS INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), KELFRED (HKEx), RESONANCE HEALTH LTD (ASX), MICRO-X LTD (ASX), STRATA SKIN SCIENCES INC (NASDAQ), NEOVASC INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), IMMUCELL CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), CELSION CORPORATION (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), AVINGER INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), MOTUS GI HOLDINGS INC (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), INCANNEX HEALTHCARE LTD (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), LBT INNOVATIONS LTD (ASX), IRIDEX CORP (NASDAQ), CHF SOLUTIONS INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), NEUROTROPE INC (NASDAQ), CARDIEX LTD (ASX), METALICITY LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), LIFE HEALTHCARE (HKEx), REWALK ROBOTICS LTD (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), AETHLON MEDICAL INC (NASDAQ), USCOM LTD (ASX), MYOS RENS TECHNOLOGY INC (NASDAQ), BIOLASE INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), CHECK-CAP LTD (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), OPTISCAN IMAGING (ASX), TENAX THERAPEUTICS INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), CYANOTECH CORP (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), DIGIRAD CORP (NASDAQ), ADHERIUM LIMITED (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), DYNATRONICS CORP (NASDAQ), STHAI (SET), VIVEVE MEDICAL INC (NASDAQ), NEUROMETRIX INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ANALYTICA (ASX), OBALON THERAPEUTICS INC (NASDAQ), HUAKANG BIOMED (HKEx), DORSAVI LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), NEUROTECH INTERNATIONAL LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.720
+28.35 %
10 Days -+1.600
+96.39 %
20 Days -+1.290
+65.48 %
Medium Term Return 3 Months -+2.960
+986.67 %
6 Months -+3.010
+1204.00 %
1 Year 0.003+3.085
+1764.57 %
Long Term Return 2 Years 0.005+3.040
+1384.09 %
3 Years 0.005+3.000
+1155.77 %
5 Years 0.011+2.980
+1068.21 %
Annualised Return Annualised --
+63.50 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.131 - 3.440 Change From 1 Year Low +3.129 % Change From 1 Year Low (%) +2388.55
Change From 1 Year High -0.180 % Change From 1 Year High (%) -5.23
2 Years Range 0.131 - 3.440 Change From 2 Years Low +3.129 % Change From 2 Years Low (%) +2388.55
Change From 2 Years High -0.180 % Change From 2 Years High (%) -5.23
5 Years Range 0.131 - 3.440 Change From 5 Years Low +3.129 % Change From 5 Years Low (%) +2388.55
Change From 5 Years High -0.180 % Change From 5 Years High (%) -5.23
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

UG Healthcare Corporation Limited manufactures and distributes natural latex and nitrile examination gloves. It markets its natural latex and nitrile examination gloves under the Unigloves brand name, as well as under third party labels. The company also distributes ancillary products, such as surgical, vinyl, and cleanroom gloves, as well as face masks and other medical disposables. Its gloves are used in healthcare, food and beverage, and automotive industries. The company markets its products in approximately 50 countries, including Germany, Nigeria, the People's Republic of China, the United States, the United Kingdom, France, Italy, Austria, Switzerland, the Netherlands, Japan, South Korea, Canada, and Brazil. UG Healthcare Corporation Limited was founded in 1989 and is based in Seremban, Malaysia.

IPO Performance

Listing Date 08 Dec 2014 Full Subscription Rate (x) 11.51
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 1.80 Public Offer Subscription Rate (x) 169.08
IPO Price (SGD) 0.215 First Day Close (SGD) 0.250 First Week Close (SGD) 0.230
Current vs IPO Price (%) +1416.28 First Day Gain (%) +16.28 First Week Gain (%) +6.98

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Jun 2019 Part 1(3.87 MB)
Annual Report 2018 Jun 2018 Part 1(3.37 MB)
Annual Report 2017 Jun 2017 Part 1(1.68 MB)
Part 2(0.17 MB)
Annual Report 2016 Jun 2016 Part 1(3.32 MB)
Annual Report 2015 Jun 2015 Part 1(1.19 MB)
IPO Prospectus
IPO Prospectus 2014 Dec 2014 Part 1(2.18 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
07 Aug 2020 3.380 3.440 3.160 3.260 8,240,800 3.3109
06 Aug 2020 3.150 3.400 3.100 3.300 6,423,800 3.2897
05 Aug 2020 2.930 3.340 2.890 3.290 9,066,900 3.1466
04 Aug 2020 2.970 2.980 2.860 2.940 5,297,000 2.9124
03 Aug 2020 2.750 2.940 2.750 2.910 7,610,600 2.8686
30 Jul 2020 2.570 2.570 2.430 2.540 4,052,000 2.5097
29 Jul 2020 2.500 2.620 2.420 2.540 11,027,600 2.5302
28 Jul 2020 1.830 2.410 1.800 2.400 28,489,400 2.1208
27 Jul 2020 1.700 1.790 1.690 1.750 4,601,400 1.7482
24 Jul 2020 1.720 1.720 1.660 1.660 2,563,300 1.6796
23 Jul 2020 1.680 1.770 1.680 1.720 2,377,500 1.7330
22 Jul 2020 1.750 1.760 1.670 1.700 2,680,900 1.7028
21 Jul 2020 1.810 1.840 1.650 1.740 5,855,900 1.7544
20 Jul 2020 1.720 1.850 1.630 1.810 11,990,300 1.7533
17 Jul 2020 1.300 1.640 1.280 1.640 11,214,500 1.4723
16 Jul 2020 1.540 1.550 1.290 1.320 9,405,800 1.4162
15 Jul 2020 1.720 1.730 1.520 1.540 6,575,000 1.6000
14 Jul 2020 1.740 1.790 1.570 1.680 6,952,500 1.6796
13 Jul 2020 2.040 2.100 1.390 1.760 21,099,700 1.8447
09 Jul 2020 1.880 2.010 1.850 1.970 15,679,000 1.9454
08 Jul 2020 1.600 1.800 1.560 1.800 12,981,600 1.6865
07 Jul 2020 1.550 1.610 1.450 1.560 13,422,300 1.5418
Summary
Current 2 Weeks
(24 Jul 2020 to 07 Aug 2020)
1.720 3.440 1.660 3.260 87,372,800 -
Previous 2 Weeks
(09 Jul 2020 to 23 Jul 2020)
1.880 3.440 1.660 1.720 93,831,100 -
4 Weeks from
(11 Jun 2020 to 08 Jul 2020)
0.800 3.440 0.725 1.800 275,203,700 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.